Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−5.19 USD
−21.02 M USD
0.00 USD
2.08 M
About Cyclerion Therapeutics, Inc.
Sector
CEO
Regina Graul
Headquarters
Cambridge
Website
Founded
2018
FIGI
BBG00KXXHYD9
Cyclerion Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of human therapeutics. Its product pipeline includes several sGC stimulators, small molecules that act synergistically with nitric oxide on sGC to boost production of cyclic guanosine monophosphate. The company was founded on September 6, 2018 and is headquartered in Cambridge, MA.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of CYCN is 2.53 USD — it has increased by 2.43% in the past 24 hours. Watch Cyclerion Therapeutics, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Cyclerion Therapeutics, Inc. stocks are traded under the ticker CYCN.
CYCN stock has fallen by −26.24% compared to the previous week, the month change is a −4.52% fall, over the last year Cyclerion Therapeutics, Inc. has showed a 2.43% increase.
CYCN reached its all-time high on Apr 2, 2019 with the price of 420.00 USD, and its all-time low was 1.75 USD and was reached on Nov 28, 2023. View more price dynamics on CYCN chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
CYCN stock is 12.40% volatile and has beta coefficient of −1.05. Track Cyclerion Therapeutics, Inc. stock price on the chart and check out the list of the most volatile stocks — is Cyclerion Therapeutics, Inc. there?
Today Cyclerion Therapeutics, Inc. has the market capitalization of 6.86 M, it has decreased by 0.00% over the last week.
Yes, you can track Cyclerion Therapeutics, Inc. financials in yearly and quarterly reports right on TradingView.
Cyclerion Therapeutics, Inc. is going to release the next earnings report on Nov 12, 2024. Keep track of upcoming events with our Earnings Calendar.
CYCN net income for the last quarter is −1.32 M USD, while the quarter before that showed −1.54 M USD of net income which accounts for 14.27% change. Track more Cyclerion Therapeutics, Inc. financial stats to get the full picture.
No, CYCN doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 11, 2024, the company has 1.00 employees. See our rating of the largest employees — is Cyclerion Therapeutics, Inc. on this list?
Like other stocks, CYCN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Cyclerion Therapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Cyclerion Therapeutics, Inc. technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Cyclerion Therapeutics, Inc. stock shows the sell signal. See more of Cyclerion Therapeutics, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.